Novo Mesto – Drug maker Krka reported a group net profit of EUR 304.7 million for 2021, a rise of 5% year-on-year, on the back of revenue that rose by 2% to a record EUR 1.57 billion, the Novo Mesto-based company said on Thursday. Chairman of the management board Jože Colarič labelled the preliminary and unaudited results as “excellent”. He told the press in Novo Mesto that in a year full of challenges, Krka performed successfully and in line with expectations – it saw record sales in all of its…
